Updated Results on PACIFIC Trial: Revise Who Should Receive Consolidation Immunotherapy?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Updated Results on PACIFIC Trial: Revise Who Should Receive Consolidation Immunotherapy?

By Beacon Medical Interchange FEATURING Jack West

431 views

November 16, 2018

Dr. Jack West discusses the trial design of the PACIFIC trial of consolidation durvalumab (Imfinzi) ...
read more ↘ after chemo/radiation for unresectable stage III NSCLC and highlights new data on overall survival and the different results in patient subgroups.
↖ read less

0 Comments